BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 24865182)

  • 1. Interactions between doctors and pharmaceutical sales representatives in a former communist country. The ethical issues.
    Makowska M
    Camb Q Healthc Ethics; 2014 Jul; 23(3):349-55. PubMed ID: 24865182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug representatives: giving you lunch or stealing your soul?
    Higgins SP
    Dermatol Online J; 2007 Oct; 13(4):5. PubMed ID: 18319002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is it pertinent to investigate the relations between physicians and the drug industry].
    Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ
    Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do gifts from the pharmaceutical industry affect trust in physicians?
    Green MJ; Masters R; James B; Simmons B; Lehman E
    Fam Med; 2012 May; 44(5):325-31. PubMed ID: 23027114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "But doctors do it...": nurses' views of gifts and information from the pharmaceutical industry.
    Jutel A; Menkes DB
    Ann Pharmacother; 2009 Jun; 43(6):1057-63. PubMed ID: 19470854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry.
    Gough IR; Dickinson I; Maddern G; Grigg M; Hillis DJ
    Med J Aust; 2010 Mar; 192(5):293-4. PubMed ID: 20201768
    [No Abstract]   [Full Text] [Related]  

  • 7. Attitudes of physicians and public to pharmaceutical industry 'gifts'.
    Macneill PU; Kerridge IH; Newby D; Stokes BJ; Doran E; Henry DA
    Intern Med J; 2010 May; 40(5):335-41. PubMed ID: 20345507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polish physicians' cooperation with the pharmaceutical industry and its potential impact on public health.
    Makowska M
    PLoS One; 2017; 12(9):e0184862. PubMed ID: 28926592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes and relationship between physicians and the pharmaceutical industry in a public general hospital in Lima, Peru.
    De Ferrari A; Gentille C; Davalos L; Huayanay L; Malaga G
    PLoS One; 2014; 9(6):e100114. PubMed ID: 24978481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.
    Wofford JL; Ohl CA
    BMC Med Educ; 2005 Feb; 5(1):5. PubMed ID: 15698480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.
    Fickweiler F; Fickweiler W; Urbach E
    BMJ Open; 2017 Sep; 7(9):e016408. PubMed ID: 28963287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
    Khazzaka M
    BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.
    Brett AS; Burr W; Moloo J
    Arch Intern Med; 2003 Oct; 163(18):2213-8. PubMed ID: 14557219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What do Libyan doctors perceive as the benefits, ethical issues and influences of their interactions with pharmaceutical company representatives?
    Alssageer MA; Kowalski SR
    Pan Afr Med J; 2013; 14():132. PubMed ID: 23734277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A national survey of physician-industry relationships.
    Sade RM
    N Engl J Med; 2007 Aug; 357(5):507; author reply 508. PubMed ID: 17671263
    [No Abstract]   [Full Text] [Related]  

  • 16. Unconscious conflict of interest: a Jewish perspective.
    Gold A; Appelbaum PS
    J Med Ethics; 2011 Jul; 37(7):402-5. PubMed ID: 20852304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of a mandatory guideline that prohibit hospital doctors from accepting any form of benefits in any form from the pharmaceutical industry].
    Gundermann C; Meier-Hellmann A; Bauer M; Hartmann M
    Dtsch Med Wochenschr; 2010 May; 135(3):67-70. PubMed ID: 20077378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doctors and drug companies.
    Blumenthal D
    N Engl J Med; 2004 Oct; 351(18):1885-90. PubMed ID: 15509823
    [No Abstract]   [Full Text] [Related]  

  • 19. Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry.
    Barnes RK
    Med J Aust; 2010 Mar; 192(5):294-5. PubMed ID: 20306549
    [No Abstract]   [Full Text] [Related]  

  • 20. Physician attitudes toward industry: a view across the specialties.
    Korenstein D; Keyhani S; Ross JS
    Arch Surg; 2010 Jun; 145(6):570-7. PubMed ID: 20566978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.